查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1294003

全球药品製造市场：按药物开发类型、剂型、治疗领域、给药途径、处方、年龄层、分销管道 - 预测 2023-2030

Pharmaceutical Manufacturing Market by Drug Development Type, Formulation, Therapy Area, Route of Administration, Prescription, Age Group, Distribution Channels - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球药品製造市场规模预计将大幅成长，2023年将达到5,723亿美元，复合年增长率为12.47%，预计到2030年将达到13,045.3亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球药品製造市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 全球药品製造市场规模及预测为何？

2. 在预测期内，COVID-19 对全球药品製造市场的阻碍因素和影响有哪些？

3. 在预测期内，全球药品製造市场需要投资哪些产品/细分市场/应用/领域？

4.全球药品製造市场的竞争策略是什么？

5. 全球药品製造市场的技术趋势和法律规范是什么？

6. 全球药品製造市场主要供应商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入全球药品製造市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 全球对疫苗和药物的需求增加
      • 医药研发支出增加
      • 老年人口增加和慢性病发生率
    • 抑制因素
      • 与生产相关的复杂性
    • 机会
      • 增加医药领域的投资和资助计划
      • 药品製造技术进步的出现
    • 任务
      • 物流复杂性和熟练专业人员有限
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章药品製造市场：依药物开发类型

  • 公司内部
  • 外包

第7章药品製造市场：按剂型

  • 胶囊
  • 可注射的
  • 粉末
  • 喷
  • 暂停
  • 药片

第8章药品製造市场：依治疗领域

  • 癌症
  • 心血管疾病
  • 糖尿病
  • 疼痛
  • 呼吸系统疾病

第9章药品製造市场：依给药途径

  • 吸入
  • 口服
  • 胃肠外的
  • 当地

第10章药品製造市场：按处方

  • 非处方药 (OTC)
  • 处方药

第11章药品製造市场：依年龄组别

  • 成人
  • 儿童和青少年
  • 对于老年人

第12章药品製造市场：依通路分类

  • 非零售
  • 零售

第13章美洲药品製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第14章亚太药品製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第15章欧洲、中东和非洲药品製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第16章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第17章上市公司名单

第18章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-8760467A9DE8

The Global Pharmaceutical Manufacturing Market is forecasted to grow significantly, with a projected USD 572.30 billion in 2023 at a CAGR of 12.47% and expected to reach a staggering USD 1,304.53 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pharmaceutical Manufacturing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pharmaceutical Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Development Type, market is studied across In-House and Outsource. The In-House is projected to witness significant market share during forecast period.

Based on Formulation, market is studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets. The Capsules is projected to witness significant market share during forecast period.

Based on Therapy Area, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases. The Cancer is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Inhalations, Oral, Parenteral, and Topical. The Inhalations is projected to witness significant market share during forecast period.

Based on Prescription, market is studied across Over-the-Counter (OTC) Medicines and Prescription Medicines. The Prescription Medicines is projected to witness significant market share during forecast period.

Based on Age Group, market is studied across Adults, Children & Adolescents, and Geriatric. The Geriatric is projected to witness significant market share during forecast period.

Based on Distribution Channels, market is studied across Non-Retail and Retail. The Non-Retail is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pharmaceutical Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Manufacturing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Manufacturing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Manufacturing Market?

4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Manufacturing Market?

5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Manufacturing Market?

6. What is the market share of the leading vendors in the Global Pharmaceutical Manufacturing Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Manufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pharmaceutical Manufacturing Market, by Drug Development Type, 2022 vs 2030
  • 4.3. Pharmaceutical Manufacturing Market, by Formulation, 2022 vs 2030
  • 4.4. Pharmaceutical Manufacturing Market, by Therapy Area, 2022 vs 2030
  • 4.5. Pharmaceutical Manufacturing Market, by Route of Administration, 2022 vs 2030
  • 4.6. Pharmaceutical Manufacturing Market, by Prescription, 2022 vs 2030
  • 4.7. Pharmaceutical Manufacturing Market, by Age Group, 2022 vs 2030
  • 4.8. Pharmaceutical Manufacturing Market, by Distribution Channels, 2022 vs 2030
  • 4.9. Pharmaceutical Manufacturing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in global demand for vaccines and drugs
      • 5.1.1.2. Growing pharmaceutical R&D spending
      • 5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities associated with the production
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the investment and funding programs in pharmaceutical manufacturing sector
      • 5.1.3.2. Emergence in the advancements of pharmaceutical manufacturing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Logistics complexities and limited skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Pharmaceutical Manufacturing Market, by Drug Development Type

  • 6.1. Introduction
  • 6.2. In-House
  • 6.3. Outsource

7. Pharmaceutical Manufacturing Market, by Formulation

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Injectable
  • 7.4. Powders
  • 7.5. Sprays
  • 7.6. Suspensions
  • 7.7. Tablets

8. Pharmaceutical Manufacturing Market, by Therapy Area

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Cardiovascular Diseases
  • 8.4. Diabetes
  • 8.5. Pain
  • 8.6. Respiratory Diseases

9. Pharmaceutical Manufacturing Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Inhalations
  • 9.3. Oral
  • 9.4. Parenteral
  • 9.5. Topical

10. Pharmaceutical Manufacturing Market, by Prescription

  • 10.1. Introduction
  • 10.2. Over-the-Counter (OTC) Medicines
  • 10.3. Prescription Medicines

11. Pharmaceutical Manufacturing Market, by Age Group

  • 11.1. Introduction
  • 11.2. Adults
  • 11.3. Children & Adolescents
  • 11.4. Geriatric

12. Pharmaceutical Manufacturing Market, by Distribution Channels

  • 12.1. Introduction
  • 12.2. Non-Retail
  • 12.3. Retail

13. Americas Pharmaceutical Manufacturing Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Pharmaceutical Manufacturing Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. FPNV Positioning Matrix
  • 16.2. Market Share Analysis, By Key Player
  • 16.3. Competitive Scenario Analysis, By Key Player

17. List of Company Mentioned

18. Appendix

  • 18.1. Discussion Guide
  • 18.2. License & Pricing

1. Actiza Pharmaceutical Pvt. Ltd.

2. Aenova Group GmbH

3. AstraZeneca PLC

4. Bayer AG

5. Boehringer Ingelheim Group

6. Bristol-Myers Squibb

7. Cipla Limited

8. Eli Lilly and Company

9. F. Hoffmann-La Roche AG

10. F. Hoffmann-La Roche Ltd.

11. Famar SA

12. GlaxoSmithKline PLC

13. Johnson & Johnson Private Limited

14. Lonza Group AG

15. Merck & Co., Inc.

16. Novartis AG

17. Novo Nordisk A/S

18. Pfizer, Inc.

19. Piramal Pharma Solutions

20. Recipharm AB

21. Sanofi S.A.

22. Sun Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2022 VS 2030 (%)
  • FIGURE 6. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2022 VS 2030 (%)
  • FIGURE 7. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 8. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2022 VS 2030 (%)
  • FIGURE 9. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
  • FIGURE 10. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2030 (%)
  • FIGURE 11. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 12. PHARMACEUTICAL MANUFACTURING MARKET DYNAMICS
  • FIGURE 13. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 24. PHARMACEUTICAL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 25. PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 15. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 26. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY PHARMACEUTICAL MANUFACTURING MA